Immune checkpoint therapy hyper-progression in renal medullary carcinoma
Автор: VJOncology
Загружено: 2026-03-05
Просмотров: 6
Описание:
Pavlos Msaouel, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses results from the Phase II study (NCT03274258) of immune checkpoint blockade in renal medullary carcinoma. Anti–PD-1 and anti–CTLA-4 combination therapy led to rapid disease progression in all treated patients, with hyperprogression observed in half of the cohort. This interview took place at the 2026 ASCO GU Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: